EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

High-Throughput Sequencing Data Reveal an Antiangiogenic Role of HNF4A-Mediated CACNA1A/VEGFA Axis in Proliferative Diabetic Retinopathy

Yuan Yin, Shuai Wu, Lingzhi Niu, Shiwei Huang

Investigative Opthalmology & Visual Science · 2023

DOI: 10.1167/iovs.64.7.32 ↗

At a glance

Journal article in Investigative Opthalmology & Visual Science, 2023. Written by Yuan Yin and 3 co-authors. Institution: Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, People's Republic of China. Major MEDLINE topics: Diabetic Retinopathy, Diabetes Mellitus. Cited 4 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Purpose

Proliferative diabetic retinopathy (PDR) is characterized by retinal new vessel formation, pointing to the importance of the antiangiogenic treatment in PDR. Hepatocyte nuclear factor 4A (HNF4A) has been highlighted to inhibit vascular endothelial growth factor (VEGF)-stimulated in vitro angiogenesis. Therefore, this study aims to elucidate the potential antiangiogenic mechanisms of HNF4A in PDR.

Methods

PDR-related high-throughput sequencing datasets (GSE94019, GSE102485, and GSE191210) were obtained from the Gene Expression Omnibus (GEO) database, followed by the screening of differentially expressed genes (DEGs). The protein-protein interaction (PPI) network of the candidate DEGs was constructed based on gene set enrichment analysis (GSEA) data and Search Tool for the Retrieval of Interacting Genes (STRING) data. In addition, the key genes and pathways related to angiogenesis were screened by functional enrichment analysis. Furthermore, human retinal microvascular cells were used for further in vitro validation.

Results

Four key genes (CACNA1A, CACNA1E, PDE1B, and CHRM3) related to PDR were identified in the grey module. CACNA1A affected angiogenesis in PDR by regulating vascular endothelial growth factor A (VEGFA) expression. Furthermore, HNF4A participated in angiogenesis in PDR by activating CACNA1A. In vitro experiments further identified that inhibition of HNF4A reduced CACNA1A expression and increased VEGFA expression, thus promoting angiogenesis in PDR.

Conclusions

In conclusion, the obtained findings suggest that antiangiogenic HNF4A activates the CACNA1A/VEGFA axis in PDR. Our work provides new insights into the angiogenic mechanism of PDR and offers potential targets for translational applications.

Subjects

MeSH terms (MEDLINE)

Diabetic RetinopathyDiabetes MellitusHumansVascular Endothelial Growth Factor AVitreous BodyRetinaRetinal VesselsCalcium ChannelsHepatocyte Nuclear Factor 4Receptor, Muscarinic M3Calcium Channels, N-Type

Substances

Vascular Endothelial Growth Factor ACalcium ChannelsHepatocyte Nuclear Factor 4Receptor, Muscarinic M3CACNA1A protein, humanCalcium Channels, N-TypeVEGFA protein, humanHNF4A protein, humanCHRM3 protein, human

Authors and institutions

  • Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, People's Republic of China.
  • Department of Ophthalmology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, People's Republic of China.

Cite

APA

Yin, Y., Wu, S., Niu, L., & Huang, S. (2023). High-Throughput Sequencing Data Reveal an Antiangiogenic Role of HNF4A-Mediated CACNA1A/VEGFA Axis in Proliferative Diabetic Retinopathy. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.64.7.32

Vancouver

Yin Y, Wu S, Niu L, Huang S. High-Throughput Sequencing Data Reveal an Antiangiogenic Role of HNF4A-Mediated CACNA1A/VEGFA Axis in Proliferative Diabetic Retinopathy. Investigative Opthalmology & Visual Science. 2023. doi:10.1167/iovs.64.7.32

BibTeX
@article{Yin2023,
  author = {Yin, Yuan and Wu, Shuai and Niu, Lingzhi and Huang, Shiwei},
  title = {High-Throughput Sequencing Data Reveal an Antiangiogenic Role of HNF4A-Mediated CACNA1A/VEGFA Axis in Proliferative Diabetic Retinopathy},
  journal = {Investigative Opthalmology & Visual Science},
  year = {2023},
  doi = {10.1167/iovs.64.7.32}
}
Start for free →